Questions remain about how the drug works and for whom The new study results flesh out earlier news of the trial released by funder Novo Nordisk in August (SN: 8/29/23 )
Patterns of discontinuation in GLP-1 agonists
Perfect fitment andHigh quality this Spoiler will not disappoint
This is significant as Schwann cells are the major glial cell type in the peripheral nervous system and play essential roles in nerve function, development, maintenance, and regeneration
The market for GLP-1 drugs alone could eventually be nearly twice as large as that for Apples iPhone was in its first decade, a new report from the Initiative for Medicines, Access & Knowledge (I-MAK) reveals GLP-1s trajectory as one of unprecedented growth, even greater than its current level of success, the report, which explores the impact of the sectors financialisation on health inequities, suggests